Roche invests $550M to expand Indianapolis diagnostics manufacturing hub

Roche announced plans to invest up to $550 million by 2030 to expand its Diagnostics site in Indianapolis, establishing it as a hub for manufacturing continuous glucose monitoring (CGM) systems. The expansion will create hundreds of jobs.

“By expanding our manufacturing capabilities in Indianapolis, we ensure reliable access to innovative monitoring solutions for individuals living with diabetes in the U.S. and worldwide.”prnewswire.com

• 1 source
• prnewswire.comRoche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hubRoche DiagnosticsMay 12, 2025

Summarized from public sources; check the original articles before acting on it.